BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18456768)

  • 1. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Huddart R; Kataja V;
    Ann Oncol; 2008 May; 19 Suppl 2():ii52-4. PubMed ID: 18456768
    [No Abstract]   [Full Text] [Related]  

  • 2. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Huddart RA
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii42-3. PubMed ID: 17491041
    [No Abstract]   [Full Text] [Related]  

  • 3. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumours (NSGCT).
    Ann Oncol; 2001 Sep; 12(9):1215-6. PubMed ID: 11697829
    [No Abstract]   [Full Text] [Related]  

  • 4. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of mixed or non-seminomatous germ cell tumors (NSGCT).
    Huddart RA; Purkalne G;
    Ann Oncol; 2005; 16 Suppl 1():i37-9. PubMed ID: 15888747
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of testicular cancer].
    Schneevoigt B; Stief CG; Karl A
    MMW Fortschr Med; 2013 Dec; 155(21-22):40-2. PubMed ID: 24724271
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recommendations Onco-Urology 2010: Germ cell testicular tumors.].
    Durand X; Rigaud J; Avances C; Camparo P; Culine S; Iborra F; Mottet N; Sèbe P; Soulié M;
    Prog Urol; 2010 Nov; 20 Suppl 4():S297-309. PubMed ID: 21129648
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis, staging, and risk factors: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
    Albers P; Algaba F; Cohn-Cedermark G; DeSantis M; Kliesch S; Moul JW
    Urology; 2011 Oct; 78(4 Suppl):S427-34. PubMed ID: 21986222
    [No Abstract]   [Full Text] [Related]  

  • 8. Testicular carcinoma. A curable malignancy.
    Dahl O
    Acta Radiol Oncol; 1985; 24(1):3-15. PubMed ID: 2984900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis, diagnosis and therapy of testicular tumors].
    Weissbach I; Bussar-Maatz R
    Urologe A; 1996 Mar; 35(2):163-72. PubMed ID: 8650851
    [No Abstract]   [Full Text] [Related]  

  • 10. [Testicular cancer. Standard management leads to recovery in 90 to 95 percent of the cases].
    Berger N; Droz JP
    Rev Prat; 2007 Feb; 57(4):361-3. PubMed ID: 17455737
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic factors in nonseminomatous testicular cancer.
    Javadpour N
    Prog Clin Biol Res; 1985; 203():271-86. PubMed ID: 2421330
    [No Abstract]   [Full Text] [Related]  

  • 12. NCCN clinical practice guidelines in oncology: testicular cancer.
    Motzer RJ; Agarwal N; Beard C; Bolger GB; Boston B; Carducci MA; Choueiri TK; Figlin RA; Fishman M; Hancock SL; Hudes GR; Jonasch E; Kessinger A; Kuzel TM; Lange PH; Levine EG; Margolin KA; Michaelson MD; Olencki T; Pili R; Redman BG; Robertson CN; Schwartz LH; Sheinfeld J; Wang J
    J Natl Compr Canc Netw; 2009 Jun; 7(6):672-93. PubMed ID: 19555582
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and therapy of testicular tumors].
    Albers P
    Urologe A; 2002 Jul; 41(4):374-85; quiz 386-7. PubMed ID: 12214458
    [No Abstract]   [Full Text] [Related]  

  • 14. The Danish testicular carcinoma study (DATECA). The DATECA Working Group.
    Dan Med Bull; 1983 Feb; 30(1):1-3. PubMed ID: 6299653
    [No Abstract]   [Full Text] [Related]  

  • 15. Testicular tumors. Multi-disciplinary approach and follow up.
    Mehdi I
    J Pak Med Assoc; 2000 Apr; 50(4):109. PubMed ID: 10851828
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of patients with non-seminomatous germ cell tumours stage I.
    Rørth M; Cullen MH; Horwich A; Roth BJ
    Prog Clin Biol Res; 1990; 357():295-303. PubMed ID: 2170995
    [No Abstract]   [Full Text] [Related]  

  • 17. [Testicular germ cell tumors, the state of diagnostics and staging in Saint-Petersburg].
    Nosov AK; Gafton GI; Meraboshvili VM; Mamizhev ÉM; Vorob'ev AV; Petrov SB
    Vopr Onkol; 2012; 58(2):238-42. PubMed ID: 22774531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-seminomatous germ cell testis tumors--how do you manage clinical state IIA?
    Whitmore WF
    Prog Clin Biol Res; 1985; 203():571-4. PubMed ID: 3008185
    [No Abstract]   [Full Text] [Related]  

  • 19. [Testicular cancer: should the contralateral testis be assessed?].
    Weissbach L
    Urologe A; 1992 Jul; 31(4):197-8. PubMed ID: 1325081
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.